Hone; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hone; David.The latest application filed is for "thermostable, chromatographically purified nano-vlp vaccine".

Company Profile

0.10.19

Hone; David - Poolesville MD
Hone; David - Bethesda MD US
Hone; David - Rockville MD
Hone; David - Ellicott City MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Thermostable, Chromatographically Purified Nano-vlp Vaccine App 20170274063 - Carra; John Howard ; et al.	2017-09-28
Multivalent vaccines comprising recombinant viral vectors Grant 8,609,402 - Havenga , et al. December 17, 2	2013-12-17
Multivalent vaccines comprising recombinant viral vectors Grant 8,202,723 - Havenga , et al. June 19, 2	2012-06-19
Multivalent vaccines comprising recombinant viral vectors App 20110281347 - Havenga; Menzo Jans Emco ; et al.	2011-11-17
Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof Grant 8,053,568 - Hone , et al. November 8, 2	2011-11-08
Multivalent vaccines comprising recombinant viral vectors App 20110256166 - Havenga; Menzo Jans Emco ; et al.	2011-10-20
Multivalent vaccines comprising recombinant viral vectors Grant 8,012,467 - Havenga , et al. September 6, 2	2011-09-06
Generation of new BCG vaccine strains protecting against the establishment of latent Mycobacterium tuberculosis infection and reactivation from the latent or persistent state Grant 7,935,354 - Flores-Valdez , et al. May 3, 2	2011-05-03
Recombinant Double-Stranded RNA Phage, and Use of the Same App 20110052628 - Hone; David	2011-03-03
Replication-proficient dsRNA capsids and uses thereof App 20100322951 - Hone; David ; et al.	2010-12-23
Recombinant double stranded RNA nucleocapsid and use of the same Grant 7,850,958 - Hone December 14, 2	2010-12-14
Novel Prime-boost Combinations Of Attenuated Mycobacterium App 20090304750 - Hone; David ; et al.	2009-12-10
Recombinant Double-Stranded RNA Phage, and Use of the Same App 20090305398 - Hone; David	2009-12-10
Recombinant double-stranded RNA phage, and use of the same Grant 7,569,219 - Hone August 4, 2	2009-08-04
Generation Of New Bcg Vaccine Strains Protecting Against The Establishment Of Latent Mycobacterium Tuberculosis Infection And Reactivation From The Latent Or Persistent State App 20090123492 - Flores-Valdez; Mario Alberto ; et al.	2009-05-14
Multivalent Vaccines Comprising Recombinant Viral Vectors App 20090123438 - Havenga; Menzo Jans Emco ; et al.	2009-05-14
Recombinant double-stranded RNA phages and uses thereof Grant 7,407,790 - Hone August 5, 2	2008-08-05
Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof App 20080107683 - Hone; David ; et al.	2008-05-08
Recombinant double-stranded RNA phage, and use of the same App 20060269570 - Hone; David	2006-11-30
Method for introducing and expressing genes in animal cells, and bacterial blebs for use in same Grant 7,125,718 - Powell , et al. October 24, 2	2006-10-24
Recombinant double stranded rna phages and uses thereof App 20060147418 - Hone; David	2006-07-06
Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof App 20060115493 - Hone; David ; et al.	2006-06-01
DNA vaccines that expresses mutant ADP-ribosyItransferase toxins which display reduced, or are devoid of, ADP-ribosyltransferase activity App 20060069052 - Hone; David	2006-03-30
Method for introducing and expressing genes in animal cells, and bacterial blebs for use in same App 20040266003 - Powell, Robert J. ; et al.	2004-12-30
DNA vaccines that expresses mutant ADP-ribosyltransferase toxins which display reduced, or are devoid of, ADP-ribosyltransferase activity App 20040171565 - Hone, David	2004-09-02
Recombinant double-stranded RNA phage, and use of the same App 20040132678 - Hone, David	2004-07-08
Genetically engineered co-expression DNA vaccines, construction methods and uses thereof App 20020193330 - Hone, David ; et al.	2002-12-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.